Societal dialog

SHARING AND EXPLAINING OUR STANDPOINTS 

Changes in science and agriculture have become the topic of passionate debate, amplified by social networks. Seeds, which involve both science and agriculture, as well as both food and nature, are the subject of many debates and virulent, even violent, disputes. They cover a multitude of subjects (intellectual property, product quality, biodiversity, breeding methods, etc.).


We are convinced it is worth contributing to the public debate by speaking with all of our stakeholders, in order to share and explain our positions on the challenges related to our seed company business.  

Protection of plant breeding

Every year, we are committed to creating and marketing more than 255 new varieties that are more productive and better adapted to the climate and specific characteristics of specific regions, and thus more resistant to disease. 

Why is plant selection essential? What are the different existing types of seeds and how can farmers access them? Why do seed companies' innovations need to be protected?

OUR POSITION ON VARIETAL DIVERSITY AND ACCESS TO SEEDS IN EUROPE

The question of GMOs

Genetically modified plants are one of the solutions to the major agricultural challenges in both today's world and in the future. At Limagrain, we are firmly convinced of this, which is why we devote 14% of our seed R&D to plant biotechnology, which includes GMOs.

Where are we at with use of GMOs? What do we know about the health risks linked to GMOs? What is Limagrain's approach to the issue?

OUR POSITION ON GMOs

Working for agricultural progress

Here at Limagrain, we consider genome editing techniques to be complementary to our selection methods. These new tools are faster and more precise, enabling us to express beneficial versions of a plant’s gene. This is why we are relentlessly pursuing our investments in these strategic technologies, as well as supporting the demand for changes in the European regulatory framework.

What do we mean exactly by genome editing and NBP? What is Limagrain's position on genome editing techniques?

OUR POSITION ON GENOME EDITING AND NBTs